Table 2. Estimates of total lifetime cost per case.
Conditions | Lifetime direct costs per incident patient (2012 Euro) | Estimated incident cases per year | Lower bound | Upper bound | Total lifetime direct costs per diagnosis (mill Euro) | Lower bound | Upper bound | References | |
a | b | C | d | a × b | a × c | a × d | |||
e | Cervical cancer | € 24,276 | 3,029 | 2,754 | 3,304 | € 73.5 | € 66.9 | € 80.2 | [26] |
f | Repeated Pap smears | € 17 | 415,000 | - | - | € 6.9 | € 6.9 | € 6.9 | [15] |
g | Management of abnormal Pap smears | € 277 | 116,000 | - | - | € 32.1 | € 32.1 | € 32.1 | [15] |
h | Diagnosis of cervical dysplasia | € 38 | 390,000 | - | - | € 14.9 | € 14.9 | € 14.9 | [12] |
i | CIN 1 treatment | € 296 | 21,308 | - | - | € 6.3 | € 6.3 | € 6.3 | [12] |
l | CIN2 treatment | € 1,625 | 3,218 | 3,218 | 7,638 | € 5.2 | € 5.2 | € 12.4 | [12], [34] |
m | CIN3 treatment | € 2,271 | 3,518 | 3,518 | 8,350 | € 8.0 | € 8.0 | € 19.0 | [12], [34] |
n | Total cervical lesions (h + i + l + m) | € 34.4 | € 34.4 | € 52.6 | |||||
o | Total cervical dysplasia (f + g + n) | € 73.4 | € 73.4 | € 91.5 | |||||
p | Total cervical conditions (e + o) | € 146.9 | € 140.2 | € 171.7 | |||||
q | Anal cancer | € 11,742 | 889 | 704 | 1,075 | € 10.4 | € 8.3 | € 12.6 | [26] |
r | Head and neck cancer | € 18,507 | 12,106 | 10,140 | 14,073 | € 224.0 | € 187.7 | € 260.5 | [26] |
s | Vulvar cancer | € 13,330 | 1,134 | 983 | 1,284 | € 15.1 | € 13.1 | € 17.1 | [26] |
t | Vaginal cancer | € 15,906 | 251 | 207 | 295 | € 4.0 | € 3.3 | € 4.7 | [26] |
u | Penile cancer | € 10,048 | 380 | 324 | 435 | € 3.8 | € 3.3 | € 4.4 | [26] |
v | Total anogenital warts (women) | € 663 | 62,250 | - | - | € 41.3 | € 41.3 | € 41.3 | [13], [19], [27] |
z | Total anogenital warts (men) | € 470 | 80,000 | - | - | € 37.6 | € 37.6 | € 37.6 | [13], [19], [27] |
y | RRP ‡ | € 187,428 | 243 | 243 | 728 | € 45.5 | € 45.5 | € 136.4 | [7], [8] |
w | Total non-cervical conditions (q + r + s + t + u + v + z + y) | € 381.7 | € 339.9 | € 514.4 | |||||
Total burden (p + w) | € 528.6 | € 480.1 | € 686.2 |
Respiratory recurrent papillomatosis (RRP).